Literature DB >> 27542822

Molecular epidemiology of extensively drug-resistant Klebsiella pneumoniae outbreak in Wenzhou, Southern China.

Jia Du1, Jianming Cao2, Lizhen Shen3, Wenzi Bi2, Xiaoxiao Zhang1, Haiyang Liu1, Hong Lu1, Tieli Zhou1.   

Abstract

The emergence of extensively drug-resistant (XDR) Klebsiella pneumoniae has become a major challenge worldwide. In this study, we characterized the phenotypes and genetic features of nine XDR K. pneumoniae isolates from an integrated hospital in Zhejiang province, China, from September to October 2014. These XDR K. pneumoniae possessed at least five resistance determinants which contribute to highly resistant to β-lactam, β-lactam/inhibitor combinations, aminoglycosides, quinolones, carbapenems, chloroamphenicol and fosfomycin. All isolates carried blaKPC-2, blaCTX-M-9, blaSHV-11 and rmtB, and several isolates also harboured blaTEM-1 and qnrS. Southern blot experiments confirmed that blaKPC-2, rmtB and blaCTX-M-9 were located on the same ~54.2 kb plasmid. Conjugative plasmids were obtained from all K. pneumoniae isolates, further proving the transferable characteristic of the resistance determinants. The OmpK36 sequences showed various deletions and insertions that indicated additional amino acid residues and a deleted phenotype of OmpK36. PFGE demonstrated that all the isolates belonged to the same genotype. Multilocus sequence typing was concordant with PFGE results and revealed that ST11 was the most predominant clone. Our study revealed a high incidence and endemic spread of XDR K. pneumoniae in the hospital. Thus, effective infection control measures should be adopted to monitor and control the spread of multidrug-resistant isolates.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27542822     DOI: 10.1099/jmm.0.000338

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  5 in total

1.  In-vivo loss of carbapenem resistance by extensively drug-resistant Klebsiella pneumoniae during treatment via porin expression modification.

Authors:  Suzanne Bialek-Davenet; Noémie Mayer; Julia Vergalli; Marion Duprilot; Sylvain Brisse; Jean-Marie Pagès; Marie-Hélène Nicolas-Chanoine
Journal:  Sci Rep       Date:  2017-07-27       Impact factor: 4.379

2.  Molecular Epidemiology of and Risk Factors for Extensively Drug-Resistant Klebsiella pneumoniae Infections in Southwestern China: A Retrospective Study.

Authors:  Xiaolang Tian; Changwu Huang; Xiaoli Ye; Hongyan Jiang; Rufang Zhang; Xiaofang Hu; Dongshuang Xu
Journal:  Front Pharmacol       Date:  2019-11-01       Impact factor: 5.810

3.  Clinical and microbiological characteristics of nosocomial, healthcare-associated, and community-acquired Klebsiella pneumoniae infections in Guangzhou, China.

Authors:  Tingting Le; Ling Wang; Chaoying Zeng; Leiwen Fu; Zhihua Liu; Jing Hu
Journal:  Antimicrob Resist Infect Control       Date:  2021-02-25       Impact factor: 4.887

Review 4.  Developing New Antimicrobial Therapies: Are Synergistic Combinations of Plant Extracts/Compounds with Conventional Antibiotics the Solution?

Authors:  Matthew J Cheesman; Aishwarya Ilanko; Baxter Blonk; Ian E Cock
Journal:  Pharmacogn Rev       Date:  2017 Jul-Dec

5.  Dynamic Epidemiology and Virulence Characteristics of Carbapenem-Resistant Klebsiella pneumoniae in Wenzhou, China from 2003 to 2016.

Authors:  Yajie Zhao; Siqin Zhang; Renchi Fang; Qing Wu; Jiahui Li; Yizhi Zhang; Andrea Rocker; Jianming Cao; Trevor Lithgow; Tieli Zhou
Journal:  Infect Drug Resist       Date:  2020-03-31       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.